據歐盟官方公報消息，2024年7月4日，歐盟委員會發布（EU）2024/1826號條例，批準由轉基因玉米DP23211組成或由其生產的食品和飼料投放市場。
據了解，該申請還涵蓋了批準含有基因改造玉米DP23211或由其組成的產品投放市場，這些產品用于除食品和飼料之外的用途（種植除外）。歐盟還在標簽、檢測方法以及監測環境影響等方面做了規定。
部分原文報道如下：
On 11 December 2019, Pioneer Overseas Corporation, based in Belgium, submitted, on behalf of Pioneer Hi-Bred International, Inc., based in the United States, an application to the national competent authority of the Netherlands (‘the application’) for the placing on the market of foods, food ingredients and feed containing, consisting of or produced from genetically modified maize DP23211, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003. The application also covered the placing on the market of products containing or consisting of genetically modified maize DP23211 for uses other than food and feed, with the exception of cultivation.On 18 January 2024, the European Food Safety Authority (‘the Authority’) issued a favourable scientific opinion (3) in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003. The Authority concluded that genetically modified maize DP23211, as described in the application, is as safe as its conventional counterpart and the tested non-genetically modified maize reference varieties with respect to the potential effects on human and animal health and the environment. The Authority also concluded that the consumption of genetically modified maize DP23211 does not represent any nutritional concern.The Standing Committee on Plants, Animals, Food and Feed has not delivered an opinion within the time limit laid down by its Chairman. This implementing act was deemed to be necessary and the chair submitted it to the appeal committee for further deliberation. The appeal committee did not deliver an opinion。
更多詳情參見：https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=OJ:L_202401826
據了解，該申請還涵蓋了批準含有基因改造玉米DP23211或由其組成的產品投放市場，這些產品用于除食品和飼料之外的用途（種植除外）。歐盟還在標簽、檢測方法以及監測環境影響等方面做了規定。
部分原文報道如下：
On 11 December 2019, Pioneer Overseas Corporation, based in Belgium, submitted, on behalf of Pioneer Hi-Bred International, Inc., based in the United States, an application to the national competent authority of the Netherlands (‘the application’) for the placing on the market of foods, food ingredients and feed containing, consisting of or produced from genetically modified maize DP23211, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003. The application also covered the placing on the market of products containing or consisting of genetically modified maize DP23211 for uses other than food and feed, with the exception of cultivation.On 18 January 2024, the European Food Safety Authority (‘the Authority’) issued a favourable scientific opinion (3) in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003. The Authority concluded that genetically modified maize DP23211, as described in the application, is as safe as its conventional counterpart and the tested non-genetically modified maize reference varieties with respect to the potential effects on human and animal health and the environment. The Authority also concluded that the consumption of genetically modified maize DP23211 does not represent any nutritional concern.The Standing Committee on Plants, Animals, Food and Feed has not delivered an opinion within the time limit laid down by its Chairman. This implementing act was deemed to be necessary and the chair submitted it to the appeal committee for further deliberation. The appeal committee did not deliver an opinion。
更多詳情參見：https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=OJ:L_202401826
